GNOM:NASDAQGlobal X Genomics & Biotechnology ETF Analysis
Data as of 2026-10-01 - not real-time
$69.56
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind Global X Genomics & Biotechnology ETF is bullish at $69.56, with short-term averages leading the long-term ones. The last 30 days have gained 4.6%. With RSI at 63.5 the momentum picture is approaching overbought, alongside a bullish MACD signal. The recent range runs from support at $61.18 up to resistance at $71.10.
The 0.50% expense ratio is middling for its category, and the fund manages $91.9M in assets.
On a 1-10 scale the risk profile lands at 6 — elevated. With 30-day volatility of 32.3%, a beta of 1.19 and a maximum drawdown of 18.2%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Timeframes disagree: the short-term read is buy while the long-term read is hold, conviction 3 out of 10.
The 0.50% expense ratio is middling for its category, and the fund manages $91.9M in assets.
On a 1-10 scale the risk profile lands at 6 — elevated. With 30-day volatility of 32.3%, a beta of 1.19 and a maximum drawdown of 18.2%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Timeframes disagree: the short-term read is buy while the long-term read is hold, conviction 3 out of 10.
Top Market Events
Quick ReadARKG's concentrated, active bet on pre-revenue biotech gained 32% YTD but lost 13 more percentage points than...Morningstar%2c Inc.2monGlobal X Genomics & Biotechnology ETFThe investment seeks to provide investment results that...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 51.57
- MACD momentum is positive
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 51.57
- MACD momentum is positive
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- 30-day volatility of 32.3%
- Beta of 1.19 versus the benchmark
Key Metrics & Analysis
Fund Metrics
Expense Ratio0.50%
AUM$91.9M
Inception Date2019-04-05
Avg Daily Volume33,480
Premium/Discount0.00%
Tracking Error0.00%
Dividend Yield1.01%
Technical Analysis
TrendBullish
RSI63.5
Support$61.18
Resistance$71.10
MA 20$66.48
MA 50$62.59
MA 200$51.57
MACDBullish
VolumeDecreasing
Fear & Greed Index92.25
Risk Assessment
Beta1.19
Volatility32.34%
Sector RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.